Published reports indicate that TIM-3 is able to downregulate immune responses under both chronic viral and cancerous conditions and it is not only highly expressed in RCC but also in several other tumor types, including melanoma, gastric cancer, etc. [18]. Here, HAVCR2 is linked to neoplasm.